Baxter International Inc. (BAX)
NYSE: BAX
· Real-Time Price · USD
22.77
-0.05 (-0.22%)
At close: Oct 15, 2025, 3:59 PM
22.70
-0.33%
After-hours: Oct 15, 2025, 04:24 PM EDT
-0.22% (1D)
| Bid | 22.5 |
| Market Cap | 11.7B |
| Revenue (ttm) | 10.89B |
| Net Income (ttm) | -155M |
| EPS (ttm) | -0.48 |
| PE Ratio (ttm) | -47.45 |
| Forward PE | 8.53 |
| Analyst | Hold |
| Dividends | $0.97 |
| Ask | 22.92 |
| Volume | 3,575,930 |
| Avg. Volume (20D) | 7,504,157 |
| Open | 22.77 |
| Previous Close | 22.82 |
| Day's Range | 22.61 - 23.30 |
| 52-Week Range | 21.33 - 37.74 |
| Beta | 0.58 |
| Ex-Dividend Date | Aug 29, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for BAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBaxter International Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-3.77%
Shares of medical technology stocks are trading lo...
Unlock content with
Pro Subscription
2 months ago
-22.42%
Baxter Intl shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered FY25 outlook.
2 months ago · youtube.com
President Trump demands drugmakers slash prices within 60 daysCNBC's Joe Kernen reports on the latest news.
2 months ago · fool.com
Baxter (BAX) Q2 Revenue Rises 4%Baxter (BAX) Q2 Revenue Rises 4%
2 months ago · seekingalpha.com
Baxter International Inc. (BAX) Q2 2025 Earnings Call TranscriptBaxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair &...
